A study found that nobiletin increases chemosensitivity to adriamycin by modulating the AKT/GSK-3β/β-catenin pathway in A549 human NSCLC cells, effectively reducing phosphorylation of β-catenin and GSK3β [91]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.